IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration

Ann Hematol. 2021 Apr;100(4):1087-1088. doi: 10.1007/s00277-020-04046-x. Epub 2020 May 4.

Authors

Johannes Ruhe¹, Hermann-Josef Gröne², Mandy Schlosser³, Claus Kroegel⁴, Gunter Wolf³, Martin Busch³

Affiliations

¹ Department of Internal Medicine III, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany. johannes.ruhe@med.uni-jena.de.
² Department of Cellular and Molecular Pathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
³ Department of Internal Medicine III, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.
⁴ Department of Internal Medicine I, Jena University Hospital, Jena, Germany.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Female
Glomerulonephritis, Membranoproliferative / complications
Glomerulonephritis, Membranoproliferative / etiology*
Glomerulonephritis, Membranoproliferative / immunology
Humans
Immunoglobulin M / blood
Immunoglobulin kappa-Chains / blood
Immunoglobulin lambda-Chains / blood
Immunoglobulins, Intravenous / administration & dosage
Immunoglobulins, Intravenous / adverse effects*
Middle Aged
Monoclonal Gammopathy of Undetermined Significance / complications
Monoclonal Gammopathy of Undetermined Significance / diagnostic imaging
Monoclonal Gammopathy of Undetermined Significance / drug therapy*
Monoclonal Gammopathy of Undetermined Significance / physiopathology
Proteinuria / blood
Ultrasonography
X-Rays

Substances

Immunoglobulin M
Immunoglobulin kappa-Chains
Immunoglobulin lambda-Chains
Immunoglobulins, Intravenous